Lilly sues online vendors, medical spa
Lilly sues online vendors, medical spa over copycat weight-loss drugs
Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound, including in the form of dissolvable tablets.
Eli Lilly's treatment for early Alzheimer's was deemed too expensive for wide use by UK's cost-effectiveness body on ...
Discussing Pfizer's platform, the lawmakers write that it "creates the impression that any patient interested in a particular ...
Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...
Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...
The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to ...
A group of U.S. senators are digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this ...
Dick Durbin (D-Ill.) demanded answers from Pfizer and Eli Lilly about their relationships with the telehealth prescribers ...
Maggie Lilly is creating a buzz with her Party of Hive granola.
The News Leader (Staunton) on MSN15h
Five Waynesboro residents ask judge to force Lilly and Mares to certify upcoming electionA counter lawsuit asking a judge to force two Waynesboro Board of Election members to certify the Nov. 5 election was filed ...
"Slim Aarons: Gold Coast" is organized by Shawn Waldron, the curator for Getty Images and manager of the Slim Aarons Archive ...
Eli Lilly & Co. closed $63.38 below its 52-week high ($972.53), which the company reached on August 22nd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback